Ryan J. Watts sold $7.4M of Denali Therapeutics (DNLI)

Executed Jul 9 2025, disclosed Jul 11 2025, 2 days later.

Value, as filed

$7.4M

495,282 sh × $15.00

Executed

Jul 9 2025

the trade date, as filed

Disclosed

Jul 11 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RW Ryan J. Watts President and CEO profile →

Ryan J. Watts (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $581K of DNLI (35,198 sh × $16.50, as filed), executed Jan 6.

The name

DNLI Denali Therapeutics Inc. DNLI · Healthcare · 12 filings in 24 months ticker →

Healthcare · Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Ryan J. Watts in DNLI

DNLISALE Denali Therapeutics Inc. $581K
35,198 sh × $16.50
Exec Jan 6
Filed Jan 8 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. $751K
36,916 sh across 2 lots
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. $1.1M
40,000 sh × $27.69
Exec Oct 18 2024
Filed Oct 22 2024 · 5:30 PM ET